The 10% reduction in output suggests Riyadh is willing to sacrifice market share to prop up prices.
The device, called Vision Pro and shaped like a pair of ski goggles, faces a skeptical consumer market and competition from others, like fellow tech giant Meta.
The streaming company plans to focus on partnerships with top podcasters.
Two of San Francisco’s largest hotels are headed to their loan servicer after their owner announced it would stop paying the debt.
Park Hotels & Resorts stopped making payments this month on a $725M CMBS loan tied to two of its San Francisco hotels. The Virginia-based real estate investment trust is looking to strengthen its balance sheet and shed the assets in San Francisco as the city continues a moribund recovery from pandemic lows.
The loan is serviced by Wells Fargo, according to CoStar, and is scheduled to mature in November. It backs the 1,921-room Hilton San Francisco Union Square and the 1,024-room Parc…
The S&P 500 could end the day 20 percent above its low point last year, marking an important milestone for some market watchers. But assessing a bona fide bull market is not so simple.
U.S. banks are planning to divest some of their commercial real estate loans — or are already doing so — to reduce their exposure to CRE, even if that means selling loans that are current at a discount, The Financial Times reports.
“The fact that banks want to sell loans is coming up in a lot of conversations,” CoStar analyst Chad Littell told the FT.
Last month, PacWest Bancorp agreed to sell a $2.6B portfolio of construction loans to investor Kennedy-Wilson Holdings. The sale included 74 loans, or more than half of the $4.6B in construction loans the company had on its books…
Chris Licht’s comments came on a morning editorial call, following an unflattering profile of him in the Atlantic.
The S.E.C. said the world’s largest cryptocurrency exchange mixed “billions of dollars” in customer funds and secretly sent them to a separate company controlled by Binance’s founder, Changpeng Zhao.
Regulator alleges in civil lawsuit that the company should have registered as securities exchange
Coherus BioSciences’ partnership to offer deeply discounted biosimilar Humira can go only so far in reducing overall prices.